Blebbistatin, a myosin II inhibitor, interferes with myosin-actin interaction and microtubule assembly. By influencing cytoskeletal dynamics blebbistatin counteracts apoptosis of several types of nucleated cells. Even though lacking nuclei and mitochondria, erythrocytes may undergo suicidal cell death or eryptosis, which is characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine exposure at the cell surface. Triggers of eryptosis include energy depletion and osmotic shock, which enhance cytosolic Ca 2ϩ activity with subsequent Ca 2ϩ -sensitive cell shrinkage and cell membrane scrambling. The present study explored the effect of blebbistatin on eryptosis. Cell membrane scrambling was estimated from binding of annexin V to phosphatidylserine at the erythrocyte surface, cell volume from forward scatter in fluorescence-activated cell sorting analysis and cytosolic Ca 2ϩ concentration from Fluo3 fluorescence. Exposure to blebbistatin on its own (1-50 M) did not significantly modify cytosolic Ca 2ϩ concentration, forward scatter, or annexin V binding. Glucose depletion (48 h) was followed by a significant increase of Fluo3 fluorescence and annexin V binding, effects significantly blunted by blebbistatin (Fluo3 fluorescence Ն 25 M, annexin V binding Ն 10 M). Osmotic shock (addition of 550 mM sucrose) again significantly increased Fluo3 fluorescence and annexin binding, effects again significantly blunted by blebbistatin (Fluo3 fluorescence Ն 25 M, annexin V binding Ն 25 M). The present observations disclose a novel effect of blebbistatin, i.e., an influence on Ca 2ϩ entry and suicidal erythrocyte death following energy depletion and osmotic shock.
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In analogy to the apoptosis of nucleated cells, erythrocytes may undergo suicidal death or eryptosis, which is characterized by cell membrane scrambling and cell shrinkage (37) . Eryptosis is stimulated by an increase of cytosolic Ca 2ϩ concentration, which may result from Ca 2ϩ entry through Ca 2ϩ -permeable cation channels (6, 25, 30, 31, 37) . Stimulators of the channels include osmotic shock and energy depletion (37, 59) . Ca 2ϩ may activate Ca 2ϩ -sensitive K ϩ channels (10, 13) with subsequent exit of KCl together with osmotically obliged water thus leading to cell shrinkage (37) . Ca 2ϩ further triggers cell membrane scrambling with exposure of phosphatidylserine at the cell surface (5, 11, 37) . The Ca 2ϩ sensitivity of cell membrane scrambling is enhanced by ceramide (36) , which is formed by a sphingomyelinase following stimulation with platelet-activating factor (37) . Erythrocyte cell membrane scrambling could be further triggered by caspases (11, 43) , which are activated by oxidative stress but are not required for the scrambling effect of Ca 2ϩ (5, 62) . Similarly, CD95 appears not to be important for suicidal erythrocyte death (55) .
Human red blood cells do express myosin (3) and form nonmuscle actinomyosin II complexes (26) , which may well modify erythrocyte integrity, survival, and/or suicidal cell death.
The present study thus explored whether blebbistatin triggers eryptosis and/or influences the eryptosis following energy depletion or hyperosmotic shock.
MATERIALS AND METHODS
Erythrocytes, solutions, and chemicals. Leukocyte-depleted erythrocytes were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003V).
Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 HEPES, 5 glucose, and 1 CaCl 2; pH 7.4 at 37°C for 48 h. Where indicated, glucose was removed or extracellular osmolarity was increased by the addition of 550 mM sucrose. Where indicated blebbistatin (Sigma, Freiburg, Germany), cytochalasin B, and cytochalasin D (both Enzo, Lörrach, Germany) were added at the indicated concentrations.
Fluorescence-activated cell sorting analysis of annexin V binding and forward scatter. After incubation under the respective experimental condition, 50 l cell suspension was washed in Ringer solution containing 5 mM CaCl 2 and then stained with Annexin-V-Fluos (1:500 dilution; Roche, Mannheim, Germany) in this solution for 20 min under protection from light. In the following, the forward scatter (FSC) of the cells was determined, and annexin V fluorescence intensity was measured in the FL-1 channel with an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a fluorescence-activated cell sorter (FACS calibur BD, Heidelberg, Germany). Determination of reactive oxygen species production. Production of reactive oxygen species (ROS) was determined utilizing 2=,7=-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 50 l suspension of erythrocytes was washed in Ringer solution and then stained with DCFDA (Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration of 10 M. Erythrocytes were incubated at 37°C for 30 min in the dark and then washed three times in Ringer solution. The DCFDA-loaded erythrocytes were resuspended in 200 l Ringer solution, and ROS-dependent fluorescence intensity was measured in the fluorescence channel FL-1 of a FACS calibur (BD).
Measurement of intracellular Ca
Estimation of the GSH/GSSG ratio. Human erythrocytes (5% hematocrit) were incubated for 48 h at 37°C in Ringer solution and in Ringer solution without glucose in the presence and absence of 50 M blebbistatin. The cells were washed twice in PBS. All manipulations were performed on ice. After lysis of 50 l of the erythrocyte pellet in 250 l distilled water and centrifugation at 14,000 rpm, 150 l of the supernatant was deproteinated by the addition of 150 l metaphosphoric acid (10%). Gluathione (GSSG and GSH) was measured with a glutathione assay kit (Cayman, Ann Arbor, MI) according to the manufacturer's protocol. The GSH/GSSG ratio refers to the concentrations within erythrocytes.
Confocal microscopy and immunofluorescence. For the visualization of eryptotic erythrocytes, 4 l of erythrocytes, incubated in respective experimental conditions, were stained with FITC-conjugated Annexin-V-Fluos (1:250 dilution; Roche) in 200 l Ringer solution containing 5 mM CaCl 2. Then the erythrocytes were washed twice and finally resuspended in 50 l of Ringer solution containing 5 mM CaCl 2. Twenty microliters were smeared onto a glass slide and covered with a coverslip, and images were subsequently taken on a Zeiss LSM 5 EXCITER confocal laser scanning microscope (Carl Zeiss MicroImaging, Oberkochen, Germany) with a water immersion Plan-Neofluar 63/1.3 NA DIC.
Statistics. Data are expressed as arithmetic means Ϯ SE. Statistical analysis was made using paired ANOVA with Tukey's test as post test, as appropriate. n denotes the number of different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to eryptotic effects, the same erythrocyte specimens have been used for control and experimental conditions.
RESULTS
As shown previously (33) , energy depletion increases cytosolic Ca 2ϩ activity, decreases cell volume, and leads to cell membrane scrambling of erythrocytes. The present study elucidated whether those events were influenced by blebbistatin.
Fluo 3 fluorescence has been used to explore whether blebbistatin influences the increase of cytosolic Ca 2ϩ concentration in erythrocytes following energy depletion by glucose withdrawal. As shown in Fig. 1 , removal of glucose for 48 h was followed by a marked increase of cytosolic Ca 2ϩ concentration. Blebbistatin exposure did not significantly influence Fluo3 fluorescence in the presence of glucose. Blebbistatin decreased, however, Fluo3 fluorescence during glucose depletion, an effect reaching statistical significance at Ն25 M. Ca 2ϩ activates K ϩ channels with subsequent exit of KCl and cell shrinkage (10, 13, 37) . Accordingly, forward scatter was determined to estimate alterations of cell volume. As shown in Fig. 2 , exposure of erythrocytes for 48 h to glucose depletion was indeed followed by a sharp decrease of forward scatter. Blebbistatin did not significantly modify forward scatter in the presence of glucose.
Ca 2ϩ further stimulates cell membrane scrambling with phosphatidylserine exposure at the cell surface. Phosphatidylserine exposing erythrocytes are identified by annexin V binding. As shown in Fig. 3 (Fig. 3) .
Additional experiments were performed to visualize eryptosis in the absence and presence of blebbistatin. As apparent from confocal microscopy (Fig. 4) , only few erythrocytes bind annexin V in the presence of glucose. A 48-h glucose deprivation increased the number of annexin V binding erythrocytes, an effect clearly blunted in the presence of 50 M blebbistatin (Fig. 4) .
Removal of glucose from Ringer solution significantly decreased the GSH/GSSG ratio, an effect, however, not significantly modified by blebbistatin. In the presence of glucose, the GSH/GSSG ratio of erythrocytes approached 17.7 Ϯ 5.0 (n ϭ 4) in the absence and 11.9 Ϯ 3.1 (n ϭ 4) in the presence of 50 M blebbistatin. After 48 h glucose depletion, the GSH/GSSG ratio approached 2.5 Ϯ 0.3 (n ϭ 4) in the absence and 3.4 Ϯ 0.5 (n ϭ 4) in the presence of 50 M blebbistain. In a further series of experiments ROS were determined utilizing DCFDAdependent fluorescence. As a result, energy depletion significantly enhanced ROS generation and blebbsitatin (50 M) did not significantly influence ROS formation. In the presence of glucose the mean DCFDA-dependent fluorescence intensities of untreated erythrocytes was not significantly different between absence (16.2 Ϯ 1.2 a.u., n ϭ 4) and presence (15.2 Ϯ 0.7 a.u., n ϭ 4) of 50 M blebbistatin. After 48 h glucose depletion, the mean fluorescence intensity was again similar in the absence (21.2 Ϯ 0.5 a.u., n ϭ 4) and presence (19.3 Ϯ 1. Eryptosis is further stimulated by osmotic shock, i.e., exposure to excessive extracellular osmolarity (37) . Additional experiments were thus performed to explore whether blebbistatin interferes with the effect of osmotic shock on erythrocytes.
As shown in Fig. 5 , exposure of erythrocytes to hyperosmolarity (addition of 550 mM sucrose) was followed by a marked increase of cytosolic Ca 2ϩ concentration. Blebbistatin exposure did not significantly influence Fluo3 fluorescence in isotonic extracellular fluid. However, blebbistatin blunted the increase of Fluo3 fluorescence following exposure of erythrocytes to osmotic shock, an effect reaching statistical significance at Ն25 M blebbistatin.
Osmotic shock further decreased the forward scatter. As shown in Fig. 6 , exposure of erythrocytes to osmotic shock was followed by a decrease of forward scatter. Blebbistatin exposure did not significantly influence forward scatter in isotonic extracellular fluid and following exposure of erythrocytes to osmotic shock (Fig. 6) .
Exposure of erythrocytes to osmotic shock further increased the percentage of erythrocytes binding annexin V, pointing to an increase of phosphatidylserine exposure at the cell surface (Fig. 7) . Blebbistatin did not significantly influence annexin V binding in isotonic extracellular fluid but blunted the increase of annexin V binding following exposure of erythrocytes to osmotic shock, an effect, again reaching statistical significance at Ն25 M blebbistatin.
DISCUSSION
The present observations demonstrate that blebbistatin interferes with the known stimulating effect of energy depletion and osmotic shock on cytosolic Ca 2ϩ concentration and cell membrane scrambling. Thus blebbistatin inhibits eryptosis.
The observations may shed new light on the functional role of myosin II in erythrocytes, which apparently plays an active part in triggering eryptosis. The membrane skeleton is considered to be required for keeping the membrane composition laterally homogeneous (58) . Moreover, myosin II bipolar minifilaments have been suggested to be involved in the restoration of the membrane skeleton following local mechanical or chemical damage (18). Myosin II activation may form stable links between distant antiparallel actin protofilaments leading to repair of the disrupted cell membrane (18). Moreover, myosin II may be involved in vesiculation of the bilayer (18). In some cells, apoptosis is paralleled by activation of the Rho-associated protein kinase ROCK following hyperactivation of actio M nomyosin (48, 65) . The Rho activation is coupled to Rac inhibition (48) . In erythroblasts, blebbistatin-sensitive myosin is apparently involved in vesicle trafficking eventually leading to enucleation (32) . Rearrangement of the cytoskeleton participates in the machinery of apoptosis (51, 54) . However, the present observations do not allow the conclusion that the anti-eryptotic effect of blebbistatin is secondary to rearrangement of microfilaments or microtubules. As neither cytoshalasin B nor cytochalasin D significantly modified the triggering of cell membrane scrambling following glucose depletion, actin depolymerization is not likely to play a role in the antieryptotic effect of blebbistatin.
As blebbistatin decreases the Ca 2ϩ entry following osmotic shock or energy depletion, myosin II may contribute to the activation of the cation channel, which mediates Ca 2ϩ entry. Blebbistatin has previously been shown to modify the activity of purinergic receptor channels (29, 52) , connexins (53), stretch-activated channels (56) , and voltage-gated Ca 2ϩ channels (44) . The erythrocyte Ca 2ϩ channels have previously been shown to involve TRPC6 (24) .
The effect of blebbistatin on Ca 2ϩ presumably accounts for its effect on eryptosis, as Ca 2ϩ activates Ca 2ϩ -sensitive K ϩ channels (10, 13) and stimulates cell membrane scrambling (5, 11, 37) . The inhibition of eryptosis by blebbistatin or related substances with more favorable pharmacological properties may be used to inhibit accelerated eryptosis. Several clinical disorders are associated with accelerated eryptosis, including iron deficiency, phosphate depletion, Hemolytic Uremic Syndrome, paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, IgA-mediated human autoimmune hemolytic anemia, sepsis, sickle cell disaease, malaria, Wilson's disease, and presumably metabolic syndrome (4, 9, 14, 15, 20, 23, 34, 37, 38, 57, 66) . Moreover, several xenobiotics and endogeneous substances stimulate eryptosis (7, 8, 12, 22, 39 -41) . Accelerated eryptosis leads to development of anemia (37) and phosphatidylserine-exposing erythrocytes may adhere to the vascular wall thus impeding microcirculation (2, 19, 27, 50, 63) . Eryptotic erythrocytes may further stimulate blood clotting (2, 16, 67) . Thus inhibition of excessive eryptosis may favorably influence the course of diseases associated with excessive eryptosis.
In conclusion, the present study reveals a novel effect of blebbistatin, i.e., inhibition of eryptosis following energy depletion and following osmotic shock.
ACKNOWLEDGMENTS
The authors acknowledge the meticulous preparation of the manuscript by Tanja Loch and Sari Rübe. 
GRANTS

